Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration to Evaluate Its Safety in Patients With Acute Myocardial Infarction

This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.

To evaluate the safety for 60 months after a single dose of Hearticellgram-AMI in patients with Acute Myocardial Infarction.

Inclusion Criteria:

1. Those who had administered Hearticellgram-AMI
2. Those who voluntarily agreed in writing to participate in this investigation

Exclusion Criteria:

-